Vijay Kedia Buys Mahamaya Lifesciences, SPML Infra: Bullish Signal

Ace investor Vijay Kedia has increased his exposure to smallcap companies in Q4, acquiring a 4.53% stake in Mahamaya Lifesciences (an SME) and a 1.88% stake in SPML Infra. This move aligns with his strategy of identifying multibagger opportunities in niche growth stories.

Vijay Kedia's investments are closely watched by the market, especially in the smallcap and SME space, as his entry often signals potential for future growth and can attract other retail and institutional investors. This could lead to increased trading volumes and price appreciation for these specific stocks.

Mahamaya Lifesciences and SPML Infra are likely to see increased investor interest and potentially positive price action due to Kedia's backing. This also highlights a broader positive sentiment towards select smallcap and SME companies with improving fundamentals.

Traders should monitor the price and volume action in Mahamaya Lifesciences and SPML Infra. Further, keep an eye on other smallcap and SME companies that exhibit similar 'niche growth story' characteristics, as they might become Kedia's next picks or attract similar investor attention.

• •Vijay Kedia acquired 4.53% in SME Mahamaya Lifesciences in Q4.
• •He added 1.88% in smallcap SPML Infra in Q4.
• •Kedia is known for spotting multibaggers early and prefers SME and niche growth stories.
• •Risk flag: Smallcap volatility
• •Risk flag: Liquidity concerns in SME stocks